These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21552299)

  • 41. Nutrition challenges in a patient with sinusoidal obstructive syndrome following an allogeneic stem cell transplant: a case study.
    Ringo K; Chen L
    Nutr Clin Pract; 2012 Oct; 27(5):651-4. PubMed ID: 22892273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome.
    Ikezoe T; Takeuchi A; Taniguchi A; Togitani K; Yokoyama A
    Bone Marrow Transplant; 2011 Apr; 46(4):616-8. PubMed ID: 20603623
    [No Abstract]   [Full Text] [Related]  

  • 43. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade.
    Carreras E; Díaz-Beyá M; Rosiñol L; Martínez C; Fernández-Avilés F; Rovira M
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1713-20. PubMed ID: 21708110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.
    Fung HC; Stein A; Slovak Ml; O'donnell MR; Snyder DS; Cohen S; Smith D; Krishnan A; Spielberger R; Bhatia R; Bhatia S; Falk P; Molina A; Nademanee A; Parker P; Rodriguez R; Rosenthal J; Sweetman R; Kogut N; Sahebi F; Popplewell L; Vora N; Somlo G; Margolin K; Chow W; Smith E; Forman SJ
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):766-71. PubMed ID: 14677116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
    Tefferi A; Kumar S; Wolf RC; Lacy MQ; Inwards DJ; Gloor JM; Albright RC; Kamath PS; Litzow MR
    Bone Marrow Transplant; 2001 Nov; 28(10):997-9. PubMed ID: 11753559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D; Martino R
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experience.
    Nagasawa M; Ohkawa T; Endo A; Mitsuiki N; Ono T; Aoki Y; Isoda T; Tomizawa D; Takagi M; Kajiwara M; Morio T; Mizutani S
    Int J Hematol; 2013 Nov; 98(5):533-42. PubMed ID: 24081926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of adult AML with t(6;11)(q27;q23) by allogeneic hematopoietic SCT in the first CR.
    Tamai H; Yamaguchi H; Takahashi S; Tojo A; Hamaguchi H; Kobayashi T; Akiyama H; Sakamaki H; Okumura H; Nakao S; Arai A; Miura O; Tajika K; Inokuchi K; Dan K
    Bone Marrow Transplant; 2008 Oct; 42(8):553-4. PubMed ID: 18622415
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of per rectal portal scintigraphy to detect portal hypertension in sinusoidal obstructive syndrome following unrelated cord blood transplantation.
    Okamura H; Hayashi Y; Nakamae H; Shiomi S; Nishimoto M; Koh H; Nakane T; Hino M
    Acta Haematol; 2013; 130(2):83-6. PubMed ID: 23548502
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
    Kebriaei P; Kline J; Stock W; Kasza K; Le Beau MM; Larson RA; van Besien K
    Bone Marrow Transplant; 2005 May; 35(10):965-70. PubMed ID: 15806131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [How to use AT concentrate or recombinant thrombomodulin for the patients with sepsis analyzed by laboratory markers].
    Eguchi Y; Yoshida T; Okabe H
    Rinsho Byori; 2011 Feb; Suppl 147():213-5. PubMed ID: 21761775
    [No Abstract]   [Full Text] [Related]  

  • 52. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
    Loren AW; Porter DL
    Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TIPS for veno-occlusive disease following stem cell transplantation.
    Schoppmeyer K; Lange T; Wittekind C; Niederwieser D; Caca K
    Z Gastroenterol; 2006 Jun; 44(6):483-6. PubMed ID: 16773513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
    Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
    Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of recombinant human soluble thrombomodulin in patients with solid carcinoma with DIC].
    Asano Y; Kashiwagi S; Shibutani M; Yamazoe S; Noda S; Sakurai K; Nagahara H; Kimura K; Kawajiri H; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohtani H; Takashima T; Yashiro M; Onoda N; Maeda K; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2503-5. PubMed ID: 25731571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should autologous or allogeneic stem-cell therapy be a part of consolidation therapy for all cases of adult acute myelogenous leukemia?
    Garcia-Manero G; Schuster SJ; Agha ME
    Semin Oncol; 1999 Feb; 26(1):xvi-xvii, xxi-xxii. PubMed ID: 10073556
    [No Abstract]   [Full Text] [Related]  

  • 57. Effective control of relapsing disseminated intravascular coagulation in a patient with decompensated liver cirrhosis by recombinant soluble thrombomodulin.
    Hasebe T; Sawada K; Nakajima S; Maeda S; Abe M; Suzuki Y; Ohtake T; Hasebe C; Fujiya M; Kohgo Y
    Intern Med; 2014; 53(1):29-33. PubMed ID: 24390524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
    Gozdzik J; Krasowska-Kwiecień A; Wedrychowicz A
    Przegl Lek; 2008; 65(4):203-8. PubMed ID: 18724548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
    Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
    Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
    J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.